Laviana Pharma
PrivateLast Round
Series C
Extension
Dec 27, 2022
Total Funding Raised
$121.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Laviana Pharma operates in Healthcare & Life Sciences and is based in Taizhou. Its latest recorded funding round was a Series C Extension round in December 2022.
Laviana Pharma is a contract development and manufacturing organization (CDMO) company that provides a one-stop service platform for small-molecule innovative drugs, from process research and development to commercial manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laviana Pharma Comparables
Compare Laviana Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 爱斯特（成都）生物制药股份有限公司 | 86% | |
| Hangzhou Lead Biotech Co., Ltd. | 83% | |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 82% |
For institutional investors. Book with your work email.
Laviana Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 27, 2022 | ||||
| Series C | Oct 13, 2021 | ||||
| Series B Extension | Sep 2, 2019 | ||||
| Series B | Apr 18, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laviana Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| V-Capital | Series B Extension |
| Puhua Capital | Series C |
| Shanghai Shiyue Asset Management | Series C |
| Shenzhen Yifeng Investment Management Enterprise | Series C Extension |
| Huayi Capital | Series C, Series B |
| LanTing Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 1320% MoM, from 46 to 653.
- Jan 20, 2026
Monthly visitors grew 136% MoM.
For institutional investors. Book with your work email.
Laviana Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laviana Pharma's valuation, stock price, and market status.
Is Laviana Pharma a public or private company?
Laviana Pharma is a private company.
What is the current stock price of Laviana Pharma?
Laviana Pharma is a private company, so its shares have no public market price. Caplight tracks Laviana Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laviana Pharma worth (valuation)?
Valuation information for Laviana Pharma is not publicly available.
Can I buy Laviana Pharma stock?
Laviana Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laviana Pharma's last funding round?
Laviana Pharma's most recent funding round was Series C Extension on December 27, 2022.
Who are the main investors in Laviana Pharma?
Key investors in Laviana Pharma include V-Capital, Shenzhen Yifeng Investment Management Enterprise, Huayi Capital.
Will Laviana Pharma IPO soon?
No public IPO plans have been announced for Laviana Pharma.
How can I track Laviana Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Laviana Pharma's shares on secondary markets.